Plant Health Care- executive interview (full)

In this video, Dr Chris Richards, Plant Health Care’s CEO, discusses FY19 performance. He comments on the status of PREtec peptide commercialisation and the impact that the COVID-19 pandemic has had on the business, noting that there has been little impact on production so far, although demand for some crop applications has been affected. He describes how he sees revenues and profitability developing once the lockdowns have eased and concludes with some remarks on the relationship with recent investor, Ospraie Ag Science.

Plant Health Care provides innovative proprietary agricultural biological products to the global agricultural market. These focus on improving crop performance, strengthening a plant’s resistance to soil pests or drought and increasing yield.

See more at: edisongroup.com/edison-tv/

Your comment